Filing metadata

Accession number
0001209191-20-004717
Form type
Form 4
Filer
Adamas Pharmaceuticals Inc
CIK
CIK 1328143
Filed
Jan 23, 2020
Reporting period
Jan 21, 2020
Description
Insider transaction

Explore SEC Filings Hub